Arboretum
Arboretum is a new approach to precision medicine for common diseases, bringing smarter diagnostics, efficient trials, and better care for millions.
$30M Series A ·
Led by F-Prime Capital · Source: pulse2.com
Funding history ↓Signals
Website registeredJan 11, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $30M | pulse2.com |
Timeline
- Website created
Investors
Companies like Arboretum
AActio Biosciences$66M Series B+ · Jun 2025
NNeuron23$97M Series B+ · Jun 2025
PPhiTech$2.4M · Apr 2026
AApothékary$16M Series A · Jun 2026TTune Therapeutics$175M Series B+ · Jan 2025
LLifeMine Therapeutics$75M Series B+ · Aug 2026
Other companies backed by F-Prime Capital
VVitriVax$87M Series B+ · Nov 2026BBoltz$110M Series A · Nov 2026
TT-Therapeutics$133M Series B+ · Nov 2026
EEka Robotics$150M Series A · Oct 2026
AAblePay Health$20M Series A · Oct 2026
RR1 Therapeutics$80.5M Series A · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arboretum (get a free API key).